Table 2 Odds of developing AD or hyperlipidemia for SNPs across APOE-APOC1 in NIH All of Us data
From: A common 19 bp APOE enhancer deletion is protective against Alzheimer’s disease in African Americans
Disease | Alzheimer’s disease (n = 656) | Hyperlipidemia (n = 102606) | ||||||
|---|---|---|---|---|---|---|---|---|
SNP | MAF | chr19 position | OR | SE | p | OR | SE | p |
rs429358 | 0.145 | 44908684 | 2.730 | 0.065 | 2.00E-53 | 1.210 | 0.010 | 1.00E-91 |
rs7412 | 0.077 | 44908822 | 0.550 | 0.131 | 5.00E-06 | 0.710 | 0.013 | 4.00E-160 |
rs1081105 | 0.027 | 44909698 | 2.250 | 0.129 | 3.00E-10 | 1.190 | 0.021 | 3.00E-17 |
rs1065853 | 0.055 | 44909976 | 0.500 | 0.165 | 2.00E-05 | 0.710 | 0.015 | 5.00E-114 |
rs148353395 | 0.029 | 44910531 | 1.320 | 0.206 | 0.173 | 1.180 | 0.023 | 4.00E-13 |
rs1081106 | 0.067 | 44910109 | 0.800 | 0.117 | 0.051 | 1.060 | 0.014 | 6.00E-05 |
rs72654471 | 0.032 | 44910852 | 0.799 | 0.215 | 0.297 | 0.991 | 0.021 | 0.657 |
rs72654473 | 0.109 | 44911142 | 0.890 | 0.094 | 0.225 | 0.810 | 0.011 | 7.00E-79 |
rs439401 | 0.636 | 44911194 | 1.220 | 0.061 | 0.001 | 1.050 | 0.007 | 7.00E-10 |
rs138235833 | 0.034 | 44912028 | 1.062 | 0.14 | 0.67 | 0.966 | 0.019 | 0.066 |
rs445925 | 0.133 | 44912383 | 0.944 | 0.087 | 0.509 | 0.863 | 0.01 | 4.90E-47 |
rs10414043 | 0.123 | 44912456 | 2.345 | 0.071 | 1.52E-33 | 1.142 | 0.01 | 2.16E-38 |
rs7256200 | 0.123 | 44912678 | 2.342 | 0.071 | 2.04E-33 | 1.143 | 0.01 | 1.72E-38 |
rs483082 | 0.25 | 44912921 | 1.683 | 0.061 | 2.03E-17 | 0.987 | 0.008 | 0.103 |
rs59325138 | 0.35 | 44913034 | 0.753 | 0.061 | 3.18E-06 | 1.054 | 0.007 | 1.47E-13 |
rs584007 | 0.639 | 44913221 | 1.212 | 0.061 | 1.59E-03 | 1.047 | 0.007 | 3.58E-10 |
rs438811 | 0.259 | 44913484 | 1.730 | 0.061 | 4.00E-19 | 0.990 | 0.008 | 0.305 |
rs390082 | 0.136 | 44913574 | 0.975 | 0.086 | 7.68E-01 | 0.867 | 0.01 | 3.18E-45 |
rs11568822 | 0.214 | 44914383 | 1.670 | 0.062 | 1.00E-16 | 0.960 | 0.008 | 8.00E-06 |